Skip to main content
Clinical Trials/EUCTR2018-002383-38-FI
EUCTR2018-002383-38-FI
Active, not recruiting
Phase 1

Premedication for less invasive surfactant administration - LISA-Med

niversity of Oulu0 sites40 target enrollmentOctober 9, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Oulu
Enrollment
40
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 9, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Oulu

Eligibility Criteria

Inclusion Criteria

  • Gestational age at birth \=26 weeks; respiratory insufficiency managed with non\-invasive respiratory support (nasal CPAP or high\-flow); requirement for oxygen to maintain oxygen saturation (SpO2\) in the target range and need for surfactant treatment (according to clinician’s assessment); if further doses of surfactant are needed, patient can be re\-randomized
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Severe RDS with high oxygen requirements, severe respiratory acidosis and/or widespread atelectasis radiologically, such that ongoing ventilator support will be necessary after surfactant therapy; maxillo\-facial, tracheal or known pulmonary malformations; any known chromosomal abnormality or severe malformation; an alternative cause for respiratory distress (e.g. congenital pneumonia or pulmonary hypoplasia)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A study to see a more appropriate strategy to provide surfactant for lung maturation in premature neonates
CTRI/2018/07/015121All India Instiute of Medical Sciences AIIMS New Delhi
Not yet recruiting
Phase 4
Extreme preterm infant non-invasive surfactant trial (EPINIST)
ACTRN12617001204336Royal Prince Alfred Hospital62
Completed
Not Applicable
Minimally invasive surfactant therapy and diaphragm activity in preterm infantsRespiratory distress syndromerespiratory problems of newborn preterm infants10028971
NL-OMON46170Academisch Medisch Centrum20
Not yet recruiting
Not Applicable
Comparison of methods of surfactant administration in premature infants.
CTRI/2023/07/055841Government medical college and hospital
Recruiting
Not Applicable
Early intratracheal treatment with surfactant plus steroids (SurPluS) in low birth-weight premature infants following preterm premature rupture of the membranes-clincal course and outcomeP23.9P25.1P26.8P28.5P27.1P52.0P52.1P52.2P52.4P36.9P39.9P77P78.0P91.1H35.1Intracerebral (nontraumatic) haemorrhage of fetus and newbornBacterial sepsis of newborn, unspecifiedInfection specific to the perinatal period, unspecifiedCongenital pneumonia, unspecifiedPneumothorax originating in the perinatal periodOther pulmonary haemorrhages originating in the perinatal periodRespiratory failure of newbornBronchopulmonary dysplasia originating in the perinatal periodIntraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 2, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newbornNecrotizing enterocolitis of fetus and newbornPerinatal intestinal perforationAcquired periventricular cysts of newbornRetinopathy of prematurity
DRKS00021504niversität zu Lübeck186